Business Overview: Centrus Energy Corp. (NYSE American: LEU)

---

Executive Summary

Centrus Energy Corp. is a Bethesda, Maryland-based supplier of nuclear fuel components and uranium enrichment services, and one of the very few Western companies with deployment-ready uranium enrichment technology. The company sells enriched uranium (measured in separative work units, or SWU) to commercial nuclear utilities, and separately runs a U.S. Department of Energy-funded program to produce HALEU (high-assay low-enriched uranium, enriched to between 5% and 20% U-235) — the fuel needed for most next-generation advanced and small modular reactors.

Centrus matters disproportionately to its size because it sits at the intersection of two major trends: the U.S. government's push to eliminate dependence on Russian-controlled enrichment supply (Rosatom/TENEX), and a surging need for HALEU to fuel the wave of advanced reactors being developed partly in response to AI-driven electricity demand growth. Centrus describes its AC100M centrifuge as "the only deployment-ready U.S. uranium enrichment technology" for national security-relevant needs, a genuinely scarce capability. Reflecting that strategic position, Centrus ended 2025 with roughly $2.0 billion in cash and a $3.8 billion order backlog, following a major run-up in government and commercial interest.

---

1. Core Business Model & How They Work

Centrus operates in two interlocking lines: buying and reselling enriched uranium to utilities, and running government-funded domestic enrichment and engineering programs.

 Natural uranium          Purchased SWU from          Centrus toll              Enriched LEU
 (customer-supplied   +   TENEX (Russia) / Orano  →   enrichment /          →   delivered to
  feedstock)               (France), plus own            blending                 utility customers
                            domestic enrichment

 DOE funding (HALEU        Piketon, Ohio               HALEU production          Advanced reactor
 Demonstration/         →  centrifuge cascade       →  (5%-20% U-235)        →   developers & DOE /
 Operation Contracts)      (AC100M technology)                                   national security use

Centrus's LEU segment generates revenue mainly by purchasing SWU (the enrichment "service" component of nuclear fuel) from foreign suppliers like TENEX and Orano and reselling it, bundled with customer-supplied natural uranium, to utility customers under medium- to long-term fixed contracts. Its Technical Solutions segment is centered on a Department of Energy contract to enrich HALEU domestically at its Piketon, Ohio facility, plus related advanced manufacturing and engineering services.

---

2. Business Segments

                         Centrus Energy Corp.
                                 │
            ┌────────────────────┴────────────────────┐
            │                                           │
         LEU Segment                          Technical Solutions Segment
      (~77% of FY2025 revenue;                (~23% of FY2025 revenue;
       $346.2M)                                $102.5M)
            │                                           │
  - Buys SWU from TENEX/Orano             - DOE HALEU Demonstration &
  - Resells enriched uranium to             Operation Contracts
    utility customers                      - AC100M centrifuge deployment
  - Long-term, fixed commitment             (Piketon, Ohio)
    contracts                             - Advanced manufacturing &
  - FY2025 gross profit: $111.5M            engineering services
                                           - Jan 2026: selected for a
                                             potential $900M HALEU
                                             production task order
                                           - FY2025 gross profit: $6.0M

The LEU segment is the larger, steadier cash generator, while Technical Solutions is the smaller but strategically critical segment carrying the company's HALEU/national-security growth story, anchored by DOE contracts whose value has grown substantially (Phase 2 of the HALEU Operation Contract reached $170.1 million by year-end 2025, and a new $900 million HALEU production task order was announced in January 2026, subject to a definitive agreement).

---

3. Product Portfolio (Key Offerings)

---

4. Competitive Landscape

The global LEU market (roughly 50 million SWU/year) is a tight oligopoly where four suppliers control over 95% of supply:

Every major competitor is owned or controlled by a foreign government, which is precisely what makes Centrus's domestic, U.S.-owned status strategically valuable even at its small current scale — it is the default (and in HALEU, essentially sole) choice for U.S. national-security and advanced-reactor fuel needs that cannot rely on foreign-controlled supply.

---

5. Strategic Strengths & Risks

Strengths:

• Scarce, deployment-ready domestic enrichment technology (AC100M centrifuge) in a market where all major competitors are foreign-government-controlled — a genuinely hard-to-replicate national-security asset.
• Large, growing backlog — $3.8 billion at year-end 2025, up from $3.7 billion, providing multi-year revenue visibility.
• Direct alignment with U.S. policy priorities: de-risking the nuclear fuel supply chain from Russia and building domestic HALEU capacity for advanced reactors.
• Exceptionally strong balance sheet — roughly $2.0 billion in cash at year-end 2025, giving it capital to fund cascade expansion without near-term dilution or debt stress.

Risks:

• Heavy reliance on government contracting and funding decisions. The company itself flags that DOE's "Option 1b" estimated cost under the HALEU Operation Contract is insufficient and needs a revised proposal — a reminder that government contract economics can shift.
• Ironic foreign-supply dependency today. Much of Centrus's current LEU volume still comes from purchasing SWU from TENEX and Orano — the very foreign-government-controlled suppliers the broader U.S. strategy aims to move away from.
• Execution risk in scaling new centrifuge cascades on time and on budget, a historically difficult engineering challenge in uranium enrichment.
• Customer/contract concentration in large utility and DOE contracts, and potential volatility tied to single large contract decisions (e.g., the pending $900 million HALEU task order is not yet a definitive agreement).

---

6. Financial Overview

---

6. Summary Conclusion

Centrus occupies a genuinely rare position: it is the only U.S.-owned company with deployment-ready uranium enrichment technology, operating in a global oligopoly where every other major player is foreign-government-controlled. That scarcity, combined with explicit U.S. policy support for de-Russifying the nuclear fuel chain and the emerging HALEU demand from advanced reactors, has produced a $3.8 billion backlog and a nearly $2.0 billion cash position. The biggest forward risk is execution and contracting risk rather than competitive risk: Centrus must successfully scale new centrifuge cascades, convert pending opportunities like the $900 million HALEU task order into definitive agreements, and navigate DOE's own contract-value negotiations (as with the underfunded "Option 1b"), all while much of its near-term LEU supply chain still runs through the foreign suppliers the broader strategy is meant to displace.